ID: ALA5198576

Max Phase: Preclinical

Molecular Formula: C28H22N6O2

Molecular Weight: 474.52

Associated Items:

Representations

Canonical SMILES:  N#Cc1ccc(-c2cncc(C3=NO[C@]4(C(=O)Nc5ccc6[nH]ncc6c5)[C@H]5CC[C@H](C5)[C@H]34)c2)cc1

Standard InChI:  InChI=1S/C28H22N6O2/c29-12-16-1-3-17(4-2-16)19-9-21(14-30-13-19)26-25-18-5-6-22(10-18)28(25,36-34-26)27(35)32-23-7-8-24-20(11-23)15-31-33-24/h1-4,7-9,11,13-15,18,22,25H,5-6,10H2,(H,31,33)(H,32,35)/t18-,22+,25-,28-/m1/s1

Standard InChI Key:  YIKSHQRPRYKWGU-MNAYGOKHSA-N

Associated Targets(Human)

Cytochrome P450 11B2 2325 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Cytochrome P450 11B1 1750 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 474.52Molecular Weight (Monoisotopic): 474.1804AlogP: 4.65#Rotatable Bonds: 4
Polar Surface Area: 116.05Molecular Species: NEUTRALHBA: 6HBD: 2
#RO5 Violations: 0HBA (Lipinski): 8HBD (Lipinski): 2#RO5 Violations (Lipinski): 0
CX Acidic pKa: 11.99CX Basic pKa: 3.82CX LogP: 3.81CX LogD: 3.81
Aromatic Rings: 4Heavy Atoms: 36QED Weighted: 0.45Np Likeness Score: -0.80

References

1. Yin L, Pan Y, Xue Y, Chen X, You T, Huang J, Xu Q, Hu Q..  (2022)  Design, Synthesis, and Biological Evaluations of Pyridyl 4,5,6,7-Tetrahydro-4,7-Methanobenzo[d]isoxazoles as Potent and Selective Inhibitors of 11β-Hydroxylase.,  65  (17.0): [PMID:35975976] [10.1021/acs.jmedchem.2c01037]

Source